JPRN-UMIN000030840招募中未知
Observation of using GLP-1 receptor agonist for wellness of brain activity in type 2 diabetes patients with mild cognitive impairment - Observation of using GLP-1 receptor Agonist for Wellness of brain Activity in type 2 diabetes patients with Mild Cognitive Impairment / OGAWA-MCI Study
Ogawa Red Cross Hospital0 个研究点目标入组 50 人开始时间: 2018年1月16日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Type 1 diabetes or suspicion of Type 1 diabetes 2)Dosing of insulin injection 3)Suspicion of dementia (MoCA-J score is 17 and below and/or MMSE score is 23 and below) 4)Dosing of weekly DPP-4 inhibitor 5)Severe ketosis, diabetic coma or precoma 6)Clinical history of pancreatitis 7)Severe infectious disease, pre/post-surgery or serious trauma 8)Severe hepatic dysfunction 9)Pituitary or adrenal gland dysfunction 10)Status of dystrophy/starvation, irregular meal intake, dietary intake deficiency or hyposthenia 11)Excessive alcohol intake 12)Clinical history of allergy or hypersensitivity to GLP-1 receptor agonists 13)Pregnant/ possible pregnant, breastfeeding 14)Psychiatric disorder 15)Inappropriate patients for study participation judged by principal or clinical investigator
研究者
相似试验
已完成
不适用
Verification of GLP-1 receptor agonist (Dulaglutide) additive effect on basal insulin therapy in patients with T2DMType2 diabetesJPRN-UMIN000024447Japan Red Cross Medical Center48
招募中
1 期
GLP-1 receptor agonists as preventive treatment of diabetes after renal transplantation: a single-arm interventional clinical trial.Study 2: Patients on the waiting list for kidney transplantation.Metabolic syndrome in patients on the waiting list for kidney transplantation, Metabolic syndrome in patients on the waiting list for kidney transplantationCTIS2023-506436-33-00Bellvitge University Hospital20
招募中
1 期
GLP-1 receptor agonists as preventive treatment of diabetes after renal transplantation: randomized clinical trial.Study 1: Immediate Kidney Transplant RecipientsPreventive treatment of post-kidney transplant diabetesCTIS2023-506437-29-00Bellvitge University Hospital128
招募中
不适用
Comparing effects of a long acting GLP-1 receptor agonist liraglutide with a short acting GLP-1 receptor agonist lixisenatide on diabetic cardiac autonomic neuropathy and glycemic variability evaluated by power spectral analysis of 24-hr heart rate and continuous glucose monitoring.Type 2 diabetesJPRN-UMIN000017144Department of Endocrinology and Metabolism, Dokkyo Medical University30
进行中（未招募）
1 期
GRAVITASTYPE 2 DIABETES MELLITUSEUCTR2014-003923-23-GBImperial College London80